Remove tag pear-therapeutics
article thumbnail

Pear Therapeutics tags another $20M to December's Series D round

Mobi Health News

The investment from "a leading national Integrated Delivery Network" brings the Series D's total to $100 million.

article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Tech-driven Solutions: Digital Therapeutics (DTx): App-based solutions offering personalized pain management programs, education, and support. Digital therapeutics (DTx) evolution: DTx platforms integrating biofeedback, cognitive behavioral therapy (CBT), and gamification for more engaging and effective pain management.

article thumbnail

The Foursquare Framework for investing in HealthTech based on Medicine Needs and Social Needs

Lloyd Price

In his view, venture capital often lean towards the therapeutics companies that fit into the low social complexity/high medical complexity quadrant, such as costly novel drugs for cancer or diabetes. In January, a single therapy to treat a rare form of blindness received a price tag of $850,000. Who's left out?